Skip to main content

User menu

  • Sign in
  • Register

Main menu

  • Pfizer Medicines
  • Therapy Areas
  • News
  • Materials
  • Useful Links

Search form

Pfizer Home
  • Champix

Clinical Information

  • Champix prescribing information
  • Be an expert in smoking cessation - Educational webinars
  • Champix and different patient types
  • Champix dosage
  • Champix efficacy vs NRT
  • Champix safety information
  • Champix tolerability
  • Champix warnings and precautions
  • Different ways to quit with Champix
  • How does Champix work?
  • Quit opportunities in smokers with comorbidities
  • The Champix 4 week pack
  • Very Brief Advice

Useful Resources

  • Video Resources (5)
  • For your patients (1)
  • Clinical References

This site is intended only for healthcare professionals resident in the United Kingdom

Welcome to CHAMPIX. Indicated for smoking cessation in adults.

The IMPACT webinar series - guidance for General Practitioners and Nurses

How to support patients through smoking cessation
Duration: 
11-13 minutes each

1. GP Stephen Gaduzo and Smoking Cessation Advisor Lisa Fendall discuss how smoking is a significant cause of long term diseases such as COPD, cardiovascular disease and diabetes and the substantial health benefits of quitting smoking for these patient groups.

Speakers

Dr Stephen Gaduzo

Nurse Lisa Fendell

2. GP Stephen Gaduzo and Smoking Cessation Advisor Lisa Fendall discuss a case study which highlights the benefits of addressing smoking cessation in primary care.  Lisa also goes into detail and demonstrates some examples of Very Brief Advice (VBA) to give to patients regarding smoking cessation.


3. GP Stephen Gaduzo and Smoking Cessation advisor Lisa Fendall discuss the nicotine addiction cycle and the mode of action, efficacy and safety data of Champix (varenicline tartrate). In particular, the flexible dosing strategies for Champix and its safety profile are discussed.

 

PP-CHM-GBR-2503.  January 2019

Related Webinars

On Demand

The IMPACT webinar series - guidance for Cardiovascular Physicians

Dr Sandy Gupta

Bernadette Downey

1. Dr Sandy Gupta and Bernadette Downey discuss the ‘deadly duo’ of smoking and cardiovascular disease and the health benefits of smoking cessation. They also highlight their experiences of the changing environment of smoking cessation services and re-enforce the need for a whole system approach across primary and secondary care.

On Demand

The IMPACT webinar series - guidance for Respiratory Physicians

Keir Lewis - Swansea University

1. Professor Keir Lewis discusses the burden of smoking and the impact that the subsequent chronic respiratory conditions in patients has on the NHS.
Pfizer Home
  • Champix

Clinical Information

  • Champix prescribing information
  • Be an expert in smoking cessation - Educational webinars
  • Champix and different patient types
  • Champix dosage
  • Champix efficacy vs NRT
  • Champix safety information
  • Champix tolerability
  • Champix warnings and precautions
  • Different ways to quit with Champix
  • How does Champix work?
  • Quit opportunities in smokers with comorbidities
  • The Champix 4 week pack
  • Very Brief Advice

Useful Resources

  • Video Resources (5)
  • For your patients (1)
  • Clinical References

Janrain Capture

  • Register / Sign in

Footer menu

  • Report Adverse Events
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • Pfizer.co.uk

Copyright footer block

Copyright © 2016-2020 Pfizer Limited. All rights reserved.
This website is brought to you by Pfizer Limited, a company registered in England and Wales under No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ, VAT registration number GB201048427.
This site is intended only for healthcare professional’s resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.
PP-PFE-GBR-2464. April 2020

For healthcare professionals only*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select ‘No’, you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer’s prescription medicines.

*The ABPI Code definition of healthcare professional is members of the medical, dental, pharmacy and nursing professions and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-GIP-GBR-3015 March 2018

YesNo
Your login attempt failed. Please try again.

{* message_withExistingAccount *}

{* loginWidget *}

{* message_joinNow *}

{* message_joinNowText *}

{* #userInformationForm *} {* traditionalSignIn_emailAddress *} {* traditionalSignIn_password *}
{* traditionalSignIn_signInButton *}

{* message_forgotPassword *}
{* /userInformationForm *}
{* traditionalSignIn_createButton *}

{* message_signIn *}

Your login attempt failed. Please try again.

{* message_welcomeBack *}

{* loginWidget *}
{* message_useAnotherAccount *}
Your login attempt failed. Please try again.

{* message_welcomeBack *}

{* #userInformationForm *} {* traditionalSignIn_emailAddress *} {* traditionalSignIn_password *}
{* traditionalSignIn_signInButton *}

{* message_forgotPassword *}
{* /userInformationForm *}
{* message_useAnotherAccount *}

{* message_registeringThankYou *}

{* message_confirmEmailSent *}

{* message_close *}

{* message_confirmTraditionalInformation *} {* message_alreadyHaveAccount *}

* Required Information

{* #registrationForm *} {* salutation *} {* givenName *} {* familyName *} {* email *} {* designation_name *} {* designation_specialty *} {* designation_specialty2 *} {* designation_specialty_json *} {* primaryAddress_workplace *} {* primaryAddress_postalCode *} {* phoneNumber_work *} {* license_number *} {* traditionalRegistration_password *} {* traditionalRegistration_passwordConfirm *} {* acknowledgement_professional *} {* acknowledgement_consent *} {* acknowledgement_terms *}
"By clicking "confirm" to create an account, you confirm that the information you have provided above is correct, and you agree to (i) Pfizer’s processing of your personal data, including its transfer internationally and to third parties, in accordance with the Pfizer Privacy and Cookie Policy; and (ii) Pfizer’s Website Terms of Use."
{* hidden_programType *} {* hidden_campaign *} {* hidden_siteId *} {* hidden_preferredLanguage *} {* hidden_residencyCountry *}

PP-PFE-GBR-2353. March 2020
{* backButton *}
{* createAccountButton *}
{* /registrationForm *}
{*#postLoginAcceptanceForm*}

{* message_legalText *}

{* postLoginAcceptanceButton *}
{*/postLoginAcceptanceForm*}

{* message_emailPasswordResetInstructions *}

{* #forgotPasswordForm *} {* traditionalSignIn_emailAddress *}
{* backButton *}
{* forgotPassword_sendButton *}
{* /forgotPasswordForm *}

{* message_emailPasswordResetSent *}

{* message_close *}
{* mergeAccounts *}
{* #tradAuthenticateMergeForm *} {* traditionalSignIn_emailAddress *} {* mergePassword *}
{* backButton *}
{* traditionalSignIn_signInButton *}
{* /tradAuthenticateMergeForm *}